vimarsana.com

Page 2 - Tidepool Loop News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Embecta Corp Reports Second Quarter Fiscal 2023 Financial Results

PARSIPPANY, N.J., May 12, 2023 (GLOBE NEWSWIRE) Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial

United kingdomUnited statesPravesh khandelwalChristian glazarPolyphotonix nocturaCompany nasdaqPolyphotonix ltdExchange commissionEmbecta corpCompany board of directorsCorporate communicationsUs food drug administrationChief executive officerQuarter fiscal yearMonths ended marchAdvanced technologies

embecta and Tidepool partner to develop automated insulin delivery system for people with Type 2 diabetes

embecta and Tidepool partner to develop automated insulin delivery system for people with Type 2 diabetes
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Henry anhaltPravesh khandelwalTidepool uploaderMediachristian glazarsrEmbecta corpCorporate communicationsChief medical officerTidepool loopChief executive officerHoward lookTidepool webTidepool mobileInvestor relations

Tidepool Announces Funding to Support Tidepool Loop for Android

Tidepool Announces Funding to Support Tidepool Loop for Android
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rayhan lalChristopher sniderTidepool uploaderSaira khan galloTidepool loopHoward lookAssistant professorAdult endocrinologyChief medical advisorTidepool webTidepool mobile

Recap: Top FDA News from Q1 2023

The top 10 most popular FDA approval articles from the first quarter of 2023, with an additional spotlight on other top regulatory news from the first 3 months of the year.

United statesDelsam pharmaCharles wykoffTidepool uploaderClinical research at retina consultants of texasDrug administrationAntimicrobial drugs advisory committeeGlobal pharma healthcare privateApellis pharmaceuticalsEmergent biosolutionsSpecial edition mind momentsLecanemab approvedRare diseaseClinical researchRetina consultantsTidepool loop

FDA Clears Automated Insulin Dosing App for Patients With Type 1 Diabetes

The FDA has cleared Tidepool Loop, an automated insulin dosing mobile application to help manage type 1 diabetes.

Diabetes technology therapeuticsDrug administrationTidepool loop

vimarsana © 2020. All Rights Reserved.